Salona Global Medical Device Corporation
Salona Global Medical Device — Investor Presentation (January 2024)
14 slides from Salona Global Medical Device's investor presentation, Jan 23, 2024
Slide 1: Investor Presentation January 2024
EVOM [= Innovations that impnro Medical Technologies Inc. for physical thera Investor Presentation January 2024 TSXV:EVMT
Slide 2: Disclaimer
Disclaimer TSXV:EVMT DISCLAIMER: This prasentation (the "Presentation’) about Evorne Medical Tachnologies Inc. "Evome” of the "Company" is datad as of January 20,2024. Itis information in a summary form andl does not purport to ‘be complata.Itis not intended to be relied upon as advice to investors
Slide 3: Financial Snapshots: Income Statement and Balance Sheet
a) Income Statement TSXVEVMT 34 Quarter ¥ Generated $19.6M in revenue for the quarter! Fi na nci a ] + 18.5% increase from previous quarter + 783% increase from same period in prior year Ss h Y Generated $7.2M in gross profit for the quarter’ na ps ot + 29% increase from previous quarter + 128.4% in
Slide 4: The Recovery
TSXV:EVMT The Recovery Science Market customers: + Athletic training rooms Physical therapy clinics + Orthopedic surgeons/sports medicine clinics + Hospitals/ambulatory surgery centers + Chiropractic centers Prevention 2;) US MARKET - $45B with 4% CAGR? + 16 million registered physical therapists wo
Slide 5: Biodex, Simbex and Mio-Guard
TSXV:EVMT v¥ Biodex: The Biodex physical medicine business is a niche brand of physical therapy clinic devices sold mainly to research institutions and large hospitals. v¥ Simbex: specializing in connected technologies; Full-stack engineering capabilities. v¥ Mioguard: Sports Medicine Supplies servi
Slide 6: Biodex Rehab Products
t TSXV:EVMT Niche brand of physical therapy clinic devices sold mainly to Biod ex Reha b research institutions and large hospitals: Products Isokinetic systems, Balance, Gait Training Fall prevention Ergonomic systems
Slide 7: From Niche to Mainstream
From Niche to Mainstream Niche Products Expensive Large footprint Complex $60,000 5,000 target customers % 4s 4s Y Available only at large hospital/ university rehabilitation centers v $85,000 v 5,000 target customers =» Mainstream Products Portable Accessible Modernized $30,000 50,000 target custom
Slide 8: SpaceTek Knee
SpaceTek Knee™ TSXV:EVMT SpaceTek Knee™ is a potential groundbreaking, portable dynamometer for knee injury rehabilitation, that was co-developed with NASAé Addresses the challenges of the Biodex System 4, including: ¥ Cost v Deployment v Ease of use Y Clinic floorspace ¥ Shipping ¥ Service logistic
Slide 9: Reactive Step Trainer — RST
Reactive Step Trainer — RST Balance Reeducation System that combines Biodex rainer and e-trip technology” The Firs! Rehab's clinically proven Gai The RST can help by retraining the neuromuscular system to respond when a person becomes off balance, with the aim of creating muscle memory when recoveri
Slide 10: Simbex provides in-house innovation expertise
Simbex provides in-house TSXV:EVMT innovation expertise ¥ Specializing in connected technologies a Rao ee 3 = V Full-stack engineering capabilities . A ¥ Commercialization strategy Riddell or ¥ 20+ year history of medical and consumer To Detect, Track & Analyze yr health device design and developmen
Slide 11: EVOME Growth Strategy
EVOME Growth TSXV:EVMT Strategy Transitioning from a niche total available market (TAM) of 5,000 potential customers to a broader TAM of 50,000 by innovating products that are portable, connected, and Al enabled3# 2025 ¥ Premier innovator in physical athletic training and fation equipment ¥ New Name
Slide 12: Mike Seckler, CEO
TSXV:EVMT Mike Seckler, CEO ¥ Appointed CEO Salona Global July 2023 ¥ Lead company turn around in 6 months ¥ Ferring Canada CEO: $100M Canadian subsidiary ¥ FerGene COO, Gene Therapy startup raised $470M Y 30+ years Life Science Leadership experience ¥ The Pennsylvania State University, BS, MBA Prov
Slide 13: References
References TSXV:EVMT L Nv GlobeNewswire Nov 15 2023 httpsi//money.tmx.com/quote/SGMD/news/8916242259576568/Salona_Global_Completes_Turn_Around_Plan_with_Profitable —Third_Quarter_Posting_Record_Results_with_185_Quarterly_Organic_Revenue_Growth_and_29_Quarterly_Gross_Profit_Gro wth_Generates_749425_i
Slide 14: Thank You
EVOME Medical Technologies Inc. THANK YOU! TSXV:EVMT
Salona Global Medical Device — Investor Presentation (January 2024) on 6ix